These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 8017461)
1. Management of postmenopausal women who have hyperlipidemia. Larosa JC Am J Med; 1994 Jun; 96(6A):19S-24S. PubMed ID: 8017461 [TBL] [Abstract][Full Text] [Related]
2. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians. Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913 [TBL] [Abstract][Full Text] [Related]
3. 2017 Taiwan lipid guidelines for high risk patients. Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI; J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176 [TBL] [Abstract][Full Text] [Related]
4. Lipid management and control of other coronary risk factors in the postmenopausal woman. Wenger NK J Womens Health Gend Based Med; 2000 Apr; 9(3):235-43. PubMed ID: 10787221 [TBL] [Abstract][Full Text] [Related]
5. A perspective on hyperlipidemia: concepts of management in the prevention of coronary artery disease. Amsterdam EA; Deedwania PC Am J Med; 1998 Jul; 105(1A):69S-74S. PubMed ID: 9707271 [TBL] [Abstract][Full Text] [Related]
7. Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease. Fukushima H; Kugiyama K; Sugiyama S; Honda O; Koide S; Nakamura S; Kawano H; Soejima H; Miyamoto S; Yoshimura M; Sakamoto T; Ogawa H Am J Cardiol; 2001 Dec; 88(12):1370-3. PubMed ID: 11741554 [TBL] [Abstract][Full Text] [Related]
8. Treatment of diabetic dyslipidemia. Garg A Am J Cardiol; 1998 Feb; 81(4A):47B-51B. PubMed ID: 9526814 [TBL] [Abstract][Full Text] [Related]
9. Hyperlipidemia in children with type 2 diabetes mellitus. Taha D J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():505-7. PubMed ID: 12017224 [TBL] [Abstract][Full Text] [Related]
10. Management of blood lipid abnormalities in coronary heart disease patients. Kuo PT Clin Cardiol; 1989 Oct; 12(10):553-60. PubMed ID: 2680196 [TBL] [Abstract][Full Text] [Related]
11. Role of risk factor management in progression and regression of coronary and femoral artery atherosclerosis. Glueck CJ Am J Cardiol; 1986 May; 57(14):35G-41G. PubMed ID: 3521250 [TBL] [Abstract][Full Text] [Related]
12. Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease. Hopkins PN; Wu LL; Hunt SC; Brinton EA J Am Coll Cardiol; 2005 Apr; 45(7):1003-12. PubMed ID: 15808755 [TBL] [Abstract][Full Text] [Related]
13. Rationale for treatment. Gotto AM Am J Med; 1991 Jul; 91(1B):31S-36S. PubMed ID: 1867234 [TBL] [Abstract][Full Text] [Related]
19. Clinical profile and long-term prognosis of women < or = 50 years of age referred for coronary angiography for evaluation of chest pain. Gurevitz O; Jonas M; Boyko V; Rabinowitz B; Reicher-Reiss H Am J Cardiol; 2000 Apr; 85(7):806-9. PubMed ID: 10758917 [TBL] [Abstract][Full Text] [Related]
20. [Application of the guideline for hyperlipidemia to primary care clinic]. Teramoto T Nihon Rinsho; 2001 Mar; 59 Suppl 3():483-91. PubMed ID: 11347118 [No Abstract] [Full Text] [Related] [Next] [New Search]